Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,602 | -6,601 | -7,925 | -6,562 | -8,876 |
| Depreciation Amortization | 782 | 159 | 111 | 55 | 220 |
| Accounts payable and accrued liabilities | -1 | -8 | 157 | 574 | 25 |
| Other Working Capital | -320 | -711 | -30 | 483 | 193 |
| Other Operating Activity | 6,808 | 1,784 | 4,170 | 4,126 | 2,640 |
| Operating Cash Flow | $-6,334 | $-5,378 | $-3,518 | $-1,324 | $-5,798 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,231 | -3,618 | -2,358 | -2,274 | -65 |
| Other Investing Activity | 0 | -1,000 | -1,000 | -1,000 | -1,000 |
| Investing Cash Flow | $-5,231 | $-4,618 | $-3,358 | $-3,274 | $-1,065 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | N/A | N/A | N/A | 6,000 |
| Common Stock Issued | 28,603 | 28,603 | 9,691 | 9,691 | N/A |
| Other Financing Activity | 736 | 736 | 211 | 186 | 511 |
| Financing Cash Flow | $34,338 | $29,338 | $9,901 | $9,876 | $6,511 |
| Beginning Cash Position | 13,923 | 13,923 | 13,923 | 13,923 | 14,275 |
| End Cash Position | 36,697 | 33,265 | 16,949 | 19,201 | 13,923 |
| Net Cash Flow | $22,774 | $19,342 | $3,026 | $5,278 | $-352 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,334 | -5,378 | -3,518 | -1,324 | -5,798 |
| Capital Expenditure | -5,231 | -3,618 | -2,358 | -2,274 | -65 |
| Free Cash Flow | -11,565 | -8,996 | -5,876 | -3,598 | -5,863 |